MRSKX
Price
$26.00
Change
+$0.03 (+0.12%)
Updated
Nov 24 closing price
Net Assets
17.24B
VTIAX
Price
$39.63
Change
+$0.33 (+0.84%)
Updated
Nov 25 closing price
Net Assets
554.27B
Interact to see
Advertisement

MRSKX vs VTIAX

Header iconMRSKX vs VTIAX Comparison
Open Charts MRSKX vs VTIAXBanner chart's image
MFS Research International R6
Price$26.00
Change+$0.03 (+0.12%)
VolumeN/A
Net Assets17.24B
Vanguard Total Intl Stock Index Admiral
Price$39.63
Change+$0.33 (+0.84%)
VolumeN/A
Net Assets554.27B
MRSKX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
MRSKX vs. VTIAX commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSKX is a StrongBuy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. MRSKX (17.2B). VTIAX pays higher dividends than MRSKX: VTIAX (2.70) vs MRSKX (1.86). MRSKX was incepted earlier than VTIAX: MRSKX (20 years) vs VTIAX (15 years). MRSKX (0.64) is less costly to investors than VTIAX (0.09). MRSKX is a more actively managed with annual turnover of: 17.00 vs. VTIAX (3.00). MRSKX has a lower initial minimum investment than VTIAX: MRSKX (0) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 20.84 vs. MRSKX (14.73). VTIAX (30.89) and MRSKX (30.50) have equivalent 5 years return.
MRSKXVTIAXMRSKX / VTIAX
Total Expense Ratio0.630.09700%
Annual Report Gross Expense Ratio0.640.09711%
Fund Existence20 years15 years-
Gain YTD17.01224.53869%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.2B554B3%
Annual Yield % from dividends1.862.7069%
Returns for 1 year14.7320.8471%
Returns for 3 years33.8642.5880%
Returns for 5 years30.5030.8999%
Returns for 10 years86.3969.88124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATEX20.500.36
+1.79%
Anterix
ALGS9.660.14
+1.52%
Aligos Therapeutics Inc
CLDX26.440.12
+0.46%
Celldex Therapeutics
HOVNP20.340.05
+0.23%
Hovnanian Enterprises
RRC37.80-0.45
-1.18%
Range Resources Corp